Anagram Therapeutics
Agent44Agent Readiness: 44/100. Above median. Measured by StartupHub.ai. Median 41.Trust75Data Trust: 75/100. Above median. Measured by StartupHub.ai. Median 61.Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
Anagram Therapeutics is a clinical-stage private biopharmaceutical company focused on improving the lives of individuals suffering from exocrine pancreatic insufficiency (EPI) caused by conditions such as cystic fibrosis, pancreatic cancer, and other related disorders. The company is developing ANG003, an orally delivered recombinant enzyme therapy.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Rare Diseases
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- anagramtx.com
- Headquarters
- Natick, Massachusetts, USA
- Founded
- 2017
- Total funding
- $285M (Investment)
- Business model
- B2B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 7 May 2026 | Investment | $250M | Blackstone |
| 5 Apr 2023 | Grant | $16M | Cystic Fibrosis Foundation |
| 20 Oct 2020 | Series A | $20M |
Tech stack
Detected on anagramtx.com, last scanned 20 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS, Bootstrap
- Analytics
- Google Analytics 4
- Email provider
- Mimecast
- Video / media
- Vimeo
Anagram Therapeutics scores 17. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Anagram Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Anagram Therapeutics is 75 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Anagram Therapeutics raised?
Anagram Therapeutics has raised a total of $285M in funding. The most recent round on record is Investment.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Anagram Therapeutics
